The Antiphospholipid Syndrome and Vascular Surgery

Abstract

Get full access to this article

View all access options for this article.

References

Hughes

G. R. V.

, The antiphospholipid syndrome: Ten years on. Lancet, 1993, 342, 341–344.

Asherson

R. A.

Cervera

, ‘Primary’, ‘Secondary’ and other variants of antiphospholipid syndrome. Lupus, 1994, 3, 293–298.

Levine

S. R.

Brey

R. L.

, Neurological aspects of antiphospholipid antibody syndrome. Lupus, 1996, 5, 347–353.

Khamashta

M. A.

Hughes

G. R. V.

, Antiphospholipid antibodies and antiphospholipid syndrome. Current Opinion in Rheumatology, 1995, 7, 389–394.

Beynon

H. L. C.

Walport

M. J.

, Antiphospholipid antibodies and cardiovascular disease. British Heart Journal, 1992, 67, 281–284.

Ordi

Selva

Monegal

Porcel

J. M.

Martinez-Costa

Vilardell

, Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis. Journal of Rheumatology, 1993, 20, 1321–1324.

Triplett

D. A.

, Assays for detection of antiphospholipid antibodies. Lupus, 1994, 3, 281–287.

Blank

Cohen

Toder

Schoenfeld

, Induction of antiphospholipid syndrome in naïve mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proceedings of the National Academy of Sciences, USA, 1991, 88, 3069–3073.

Galli

Comfurius

Maassen

Hemker

H. C.

De Baets

M. H.

Van Breda-Variesman

P. J. C.

Barbui

Zwaal

R. F. A.

Bevers

E. M.

, Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet, 1990, 335, 1544–1547.

10.

McNeil

H. P.

Simpson

R. J.

Chesterman

C. N.

Krilis

S. A.

, Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proceedings of the National Academy of Sciences, USA, 1990, 87, 4120–4124.

11.

Lee

N. S.

Brewer

B. H.

Osborne

J. C.

, Beta-2-glycoprotein I: Molecular properties of an unusual apolipoprotein, apolipoprotein H. Journal of Biological Chemistry, 1983, 258, 4765–4770.

12.

Steinkasserer

Barlow

P. N.

Willis

A. C.

Kertesz

Campbell

I. D.

Sim

R. B.

Norman

D. G.

, Activity, disulphide mapping and structural modelling of the fifth domain of human β2-glycoprotein I, FEBS Letters, 1992, 313, 193–197.

13.

Matsuura

Igarashi

Yasuda

Triplett

Koike

, Anticardiolipin antibodies recognize β₂-GPI structure altered by interacting with an oxygen-modified solid phase surface. Journal of Experimental Medicine, 1994, 179, 457–462.

14.

Hunt

J. E.

Simpson

R. J.

Krilis

S. A.

, Identification of a region of beta-2-glycoprotein I critical for lipid-binding and anticardiolipin cofactor activity. Proceedings of the National Academy of Sciences, USA, 1993, 90, 2141–2145.

15.

Kandiah

D. A.

Hunt

J. E.

Krilis

S. A.

, Epitope mapping studies of antiphospholipid antibodies and beta 2-GPI using synthetic epitopes. Lupus, 1995, 4 (suppl. 1), S7–S11.

16.

Brighton

T. A.

Hogg

P. J.

Dai

Y.-P.

Murray

B. H.

Chong

B. H.

Chesterman

C. N.

, Beta2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant. British Journal of Haematology, 1996, 93, 185–194.

17.

Roubey

R. A. S.

, Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other ‘antiphospholipid’ autoantibodies. Blood, 1994, 84, 2854–2867.

18.

Bajaj

S. P.

Rapaport

S. I.

Fierer

D. S.

Herbst

K. D.

Schwartz

D. B.

, A mechanism for the hypoprothrombinaemia of the acquired hypoprothrombinaemia-lupus anticoagulant syndrome. Blood, 1983, 61, 684–692.

19.

Oosting

J. D.

Derksen

R. H. W. M.

Bobbink

I. W. G.

Hackeng

T. M.

Bouma

B. N.

De Groot

P. G.

, Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C., or protein S: An explanation for their pathogenic mechanism?. Blood, 1993, 81, 2618–2625.

20.

Arnout

, The pathogenesis of the antiphospholipid syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 1996, 75(4), 536–541.

21.

Galli

Daldossi

Barbui

, Antiglycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies. Thrombosis and Haemostasis, 1994, 71, 571–575.

22.

Machin

S. J.

, Platelets and antiphospholipid antibodies. Lupus, 1996, 5, 386–387.

23.

Vianna

J. L.

Khamashta

M. A.

Ordi-Ros

Font

Lopez-Soto

Tolosa

Franz

Selva

Ingelmo

Vilardell

Hughes

G. R. V.

, Comparison of the primary and secondary antiphospholipid syndrome: A European multicentre study of 114 patients. American Journal of Medicine, 1994, 36, 3–9.

24.

Donaldson

M. C.

Weinberg

D. S.

Belkin

Whittemore

A. D.

Mannick

J. A.

, Screening for hypercoagulable states in vascular surgical practice: A preliminary study. Journal of Vascular Surgery, 1990, 11, 825–831.

25.

Valentine

R. J.

Kaplan

H. S.

Green

Jacobsen

D. W.

Myers

S. I.

Clagett

G. P.

, Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective, controlled analysis. Journal of Vascular Surgery, 1996, 23, 53–61.

26.

Asherson

R. A.

Khamashta

Gil

Vazquez

Chan

Baguley

Hughes

G. R. V.

, Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. American Journal of Medicine, 1989, 86, 391–399.

27.

Herranz

M. R.

Rivier

Khamashta

M. A.

Blaser

K. U.

Hughes

G. R. V.

, Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 1994, 37, 568–571.

28.

Toubi

Khamashta

M. A.

Panarro

Hughes

G. R. V.

, Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. American Journal of Medicine, 1995, 99, 397–401.

29.

Bell

C. L.

Parkington

Robbins

Graziano

Turski

Kornguth

, Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus: Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis and Rheumatism, 1991, 34(4), 432–441.

30.

Scott

T. F.

Hess

Brillman

, Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Archives of Internal Medicine, 1994, 154, 917–920.

31.

Pelletier

Landi

Piette

J. C.

Ekert

Coutellier

Desmoulins

Fadlallah

J. P.

Herson

Valla

, Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. Journal of Hepatology, 1994, 21, 76–80.

32.

Piette

J. C.

Cacoub

Wechsler

, Renal manifestations of the antiphospholipid syndrome. Seminars in Arthritis and Rheumatism, 1994, 23, 357–366.

33.

Barbut

Borer

J. S.

Gharavi

Wallerson

Devereux

R. B.

Supino

Suite

N. D. A.

, Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events. American Journal of Cardiology, 1992, 70, 901–905.

34.

Nihoyannopoulos

Gomez

P. M.

Joshi

Loizou

Walport

M. J.

Oakley

C. M.

, Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation, 1990, 82(2), 369–375.

35.

Khamashta

M. A.

Cervera

Asherson

R. A.

Font

Gil

Coltart

D. J.

Vazquez

J. J.

Pare

Ingelmo

Oliver

Hughes

G. R. V.

, Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet, 1990, 335, 1541–1544.

36.

Roldan

C. A.

Shively

B. K.

Lau

C. C.

Gurule

F. T.

Smith

E. A.

Crawford

M. H.

, Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. Journal of the American College of Cardiology, 1992, 20, 1127–1134.

37.

Kaplan

S. D.

Chartash

E. K.

Pizzarello

R. A.

Furie

R. A.

, Cardiac manifestations of the antiphospholipid syndrome. American Heart Journal, 1992, 124(5), 1331–1338.

38.

Hamsten

Norberg

Bjorkholm

De Faire

Holm

, Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet, 1986, 1, 113–116.

39.

Mattila

Vaarala

Palosuo

Malkamaki

Valtonen

Nieminen

Aho

, Serological response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction. Clinical Immunology and Immunopathology, 1989, 51, 414–418.

40.

Morton

K. E.

Gavaghan

T. P.

Krilis

S. A.

Daggard

G. E.

Baron

D. W.

Hickie

J. B.

Chesterman

C. N.

, Coronary artery bypass graft failure — An autoimmune phenomenon?. Lancet, 1986, 2, 1353–1357.

41.

Asherson

R. A.

Higenbottam

T. W.

Xuan

A. T. Dinh

Khamashta

M. A.

Hughes

G. R. V.

, Pulmonary hypertension in a lupus clinic: Experience with twenty-four patients. Journal of Rheumatology, 1990, 17, 1292–1298.

42.

Asherson

R. A.

Piette

J. C.

, The catastrophic antiphospholipid syndrome 1996: Acute multi-organ failure associated with antiphospholipid antibodies: A review of 31 patients. Lupus, 1996, 5, 414–417.

43.

Khamashta

M. A.

Cuadrado

M. J.

Mujic

Taub

N. A.

Hunt

B. J.

Hughes

G. R. V.

, The management of thrombosis in the antiphospholipid syndrome. New England Journal of Medicine, 1995, 332, 993–997.

44.

Asherson

R. A.

Chan

J. K.

Harris

E. N.

Gharavi

A. E.

Hughes

G. R.

, Anticardiolipin antibodies, recurrent thrombosis and warfarin withdrawal. Annals of Rheumatic Disease, 1985, 44, 823–825.

45.

Rosove

M. H.

Brewer

P. M. C.

, Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Annals of Internal Medicine, 1992, 117, 303–308.

46.

Ginsburg

J. S.

Wells

P. S.

Brill-Edwards

Donovan

Moffatt

Johnston

Stevens

Hirsh

, Antiphospholipid antibodies and venous thrombosis. Blood, 1995, 86, 3685–3691.

47.

Khamashta

M. A.

Mackworth-Young

, Antiphospholipid (Hughes') syndrome. British Medical Journal, 1997, 314, 244.

48.

Lima

Khamashta

Buchanan

N. M. M.

Kerslake

Hunt

B. J.

Hughes

G. R. V.

, A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clinical and Experimental Rheumatology, 1996, 14, 131–136.

49.

Hunt

B. J.

Doughty

Majumdar

Copplestone

Kerslake

Buchanan

Hughes

Khamashta

, Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thrombosis and Haemostasis, 1997, 77(1), 39–43.